Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Should the new pneumococcal vaccine be used in high-risk children?

Finn, A; Booy, R; Moxon, R; Sharland, M; Heath, P (2002) Should the new pneumococcal vaccine be used in high-risk children? ARCHIVES OF DISEASE IN CHILDHOOD, 87 (1). 18 - 21 (4). ISSN 0003-9888
SGUL Authors: Heath, Paul Trafford Sharland, Michael Roy

Full text not available from this repository.
Item Type: Article
Additional Information: PubMed ID: 12089114
Keywords: Anemia, Sickle Cell, Child, Preschool, Chronic Disease, Humans, Immunologic Deficiency Syndromes, Immunosuppressive Agents, Infant, Meningococcal Vaccines, Pneumococcal Infections, Pneumococcal Vaccines, Risk Factors, Splenectomy, Splenic Diseases, Subdural Effusion, Transplantation, Science & Technology, Life Sciences & Biomedicine, Pediatrics, SICKLE-CELL DISEASE, IMMUNODEFICIENCY-VIRUS INFECTION, CONJUGATE VACCINE, POLYSACCHARIDE VACCINE, STREPTOCOCCUS-PNEUMONIAE, NASOPHARYNGEAL CARRIAGE, YOUNG-ADULTS, IMMUNOGENICITY, SAFETY, IMMUNIZATION
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: ARCHIVES OF DISEASE IN CHILDHOOD
ISSN: 0003-9888
Related URLs:
1 July 2002Published
Web of Science ID: WOS:000176838000008
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Publisher's version:

Actions (login required)

Edit Item Edit Item